NYSE: DXDynex Capital Inc Stock
$11.48-0.04 (-0.35%)
Updated Apr 18, 2024
DX Price
$11.48
Fair Value Price
N/A
Market Cap
$672.09M
52 Week Low
$9.57
52 Week High
$13.56
P/E
-45.92x
P/B
0.77x
P/S
25.65x
PEG
N/A
Dividend Yield
13.59%
Revenue
$26.75M
Earnings
-$6.13M
Gross Margin
100%
Operating Margin
-22.92%
Profit Margin
-51.7%
Debt to Equity
6.32
Operating Cash Flow
$62M
Beta
0.8
Next Earnings
Apr 22, 2024
Ex-Dividend
Apr 22, 2024
Next Dividend
May 1, 2024
DX Overview
Dynex Capital, Inc., a mortgage real estate investment trust (REIT), invests in mortgage-backed securities (MBS) on a leveraged basis in the U.S. It invests in agency and non-agency MBS consisting of residential MBS, commercial MBS (CMBS), and CMBS interest-only securities. The company was incorporated in 1987 and is headquartered in Glen Allen, VA.
Zen Score
–
Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DX is poor value based on its book value relative to its share price (0.77x), compared to the US REIT - Mortgage industry average (0.69x)
P/B vs Industry Valuation
DX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more DX due diligence checks available for Premium users.
Be the first to know about important DX news, forecast changes, insider trades & much more!
DX News
Valuation
DX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-45.92x
Industry
37.18x
Market
41.33x
DX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.77x
Industry
0.69x
DX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
DX's financial health
Profit margin
Revenue
$33.1M
Net Income
$24.3M
Profit Margin
67.6%
DX's Earnings (EBIT) of -$6.13M... subscribe to Premium to read more.
Interest Coverage Financials
DX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$6.4B
Liabilities
$5.5B
Debt to equity
6.32
DX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$16.6M
Investing
-$556.0M
Financing
$360.8M
DX's operating cash flow ($62.20M)... subscribe to Premium to read more.
Debt Coverage Financials
DX vs Mortgage REIT Stocks
Dynex Capital Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.